Background: Obesity is a complex, medical condition causally contributing to many chronic diseases and a number of efforts have been made to find the associated markers for novel prevention and treatment of obesity. Our study was to evaluate the relationship between gut immune response and obesity and overweight with use of fecal calprotectin (FC) both in adult and children groups. Methods: Fecal samples were obtained from 74 subjects: 14 non-obese and overweight children (PN), 13 obese and overweight children (PO), 20 non-obese and overweight adults (AN), and 27 obese and overweight adults (AO). FC was measured using a commercial Legend Max quantitative enzyme-linked immunosorbent assay (BioLegend). Mann-Whitney U-test was used for statistical analysis. Results: Median FC concentration was 7.9 μg/g (range, 1.9-28.9 μg/g) for PN, 5.0 μg/g (range, 2.6-29.6 μg/g) for PO, 9.5 μg/g (range, 0.8-28.9 μg/g) for AN, and 10.0 μg/g (range, 1.6-25.6 μg/g) for AO, respectively. In both adults and children age groups, the FC showed no statistically significant difference between AO and AN or PO and PN. However, FC showed statistically significant difference (P<0.05) between AO and PO while not significant between AN and PN. Conclusion: FC level in AO was significantly higher than that in PO, suggestive of different pathophysiologic mechanism between children obesity and adults obesity.
INTRODUCTION
Obesity contribute substantially to mortality and are major risk factors for many chronic diseases including diabetes, vascular disease, and cancer. 1 Obesity and overweight in both children and adults continues to rise globally. 2 A number of efforts have been made to find the associated markers in the quest for novel prevention and treatment of obesity. The studied markers include adipocytic markers (adipokines: leptin, adiponectin) 
METHODS

Subjects
In the present study, fecal samples were obtained from 74 subjects: 14 non-obese and overweight children (PN), 13 obese and overweight children (PO), 20 non-obese and overweight adults (AN), and 27 obese and overweight adults (AO) ( Table 1) . Written informed consent was obtained from the subjects or their guardians. Diagnosis was based on the World Health Organization criteria in Asians as those with a BMI ≥ 23 and ≥ 25 kg/m 2 for overweight and obese adult 10 and criteria of Korea Centers for Disease
Control Prevention as those with BMI ≥ 85th and ≥ 95th percentiles for overweight and obese children. 11 The subjects in the study met the exclusion criteria , based on a study of factors affecting levels of FC 
Fecal calprotectin
Subjects provided a single fecal sample for calprotectin measure- 
Statistics
Data were analyzed using the GraphPad Prism (GraphPad Software, La Jolla, CA, USA) statistical software package. Calprotectin values were presented as mean ± standard deviation, median and ranges. A Student t-test was used to evaluate the significance of the mean differences of demographic characteristics between PN, PO 
RESULTS
Median FC concentration was 7.9 μg/g (range, 1.9-28.9 μg/g) for PN, 5.0 μg/g (range, 2.6-29.6 μg/g) for PO, 9.5 μg/g (range, 0.8-28.9 μg/g) for AN, and 10.0 μg/g (range, 1.6-25.6 μg/g) for AO, respectively (Table 2 ). In both adult and children age groups, the FC showed no statistically significant difference between AO and AN or PO and PN. However, in detail, FC was higher in AO than in AN while in children, the FC was higher in PN than in PO though statistically not significant. FC showed statistically significant difference between AO and PO while FC showed no significant difference between AN and PN (Fig. 1) . The correlation analyses showed no significant correlation between FC and BMI in child and/or adult groups.
DISCUSSION
Growing research suggests that obesity is not a simple phenomenon form improper diet and lifestyle, but a multi-factorial medical condition beyond individuals' control. 13 Among the factors, growing evidence suggests inflammatory links with obesity. Tumor necrosis factor (TNF)-α expression in the adipose tissue was reported to be increased in obese humans several decades ago. 14 Recent mice experiments showed that only TNF-α among multiple inflammatory cytokines was upregulated by high fat diets specifically in the ileum before weight gain and increase in fat mass. 15 Our results in adult groups are consistent with the reports by Mendall et al. 12 In a middle-aged healthy general population sample of 300 subjects (range, 50-70 years), they reported that the relationship ) and found interesting finding that FC was only detectable in obese subjects with an obese pattern of microbiota. In contrary to adult groups, case control studies in pediatric groups are rare and a few reports about FC levels studied only in obese children. Spagnuolo et al. 18 studied 35 children with severe obesity (BMI > 95%) and found that FC was increased only in 47% patients while CRP in 73.5%. Taken together, larger scale study and stratification based on other indicators such as gut microbiota composition than BMI is warranted.
The other interest finding in our result is that FC showed statistically significant difference between obese and overweight adult and obese and overweight children while FC showed no statistically significant difference between non-obese and overweight adults Calprotectin is secreted extracellularly from stimulated neutrophils and the FC levels of healthy children exhibit a downward trend with increasing age and reach the adult level by the age of four. 19, 20 This finding is consistent with recent FC study in healthy children aged less than 4 years in South Korea. 21 The Formula-fed boys (38.6%) were significantly more likely to be obese than breast-fed boys (23.4%, P< 0.01). 23 The ontogeny study of the immune system by type of infant feeding showed that blood cells of lymphoid lineage did not change significantly in frequencies or composition from 1.5 to 6 months of age in breast-fed infants. In contrast, formula-fed infants displayed an ongoing maturation of adaptive immunity cells and a delayed recruitment of innate immunity cells as compared with breast-fed infants. 24 Obesity is a well-established risk factor for venous thromboembolism in adults in contrary to children. 25 Taken these together, our finding and the above reports suggest different pathophysiologic background between adult obesity and children obesity. One possible explanation involves adaptive immunity behind children obesity and innate immunity behind adult obesity, and it warrants further research to elucidate exact mechanism and associated links between host gut immunity and obesity as inflammation. In conclusion, FC level in AO was significantly higher than that in PO, suggestive of different pathophysiologic mechanism between childhood and adulthood obesity. Further study is needed.
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